Literature DB >> 9613860

Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).

A C Smith1, E Dykens, F Greenberg.   

Abstract

Smith-Magenis syndrome (SMS) is a clinically recognizable multiple congenital anomaly and mental retardation syndrome caused by an interstitial deletion of chromosome 17 p11.2. Although the physical and molecular genetic features of SMS are increasingly well understood, work is more limited on SMS's behavioral phenotype, which includes self-injury, tantrums, and sleep disturbance. This study examines the sleep behaviors of 39 individuals with SMS, ranging in age from 1.6 to 32 years (mean = 10.5). Prominent sleep problems, seen in 65 to 100% of the sample, included difficulties falling asleep, shortened sleep cycles, frequent and prolonged nocturnal awakenings, excessive daytime sleepiness, daytime napping, snoring, and bed-wetting. Medication to facilitate sleep was used by 59% of SMS subjects. Possible etiologic mechanisms of sleep disturbance in SMS are discussed, as are recommended interventions.

Entities:  

Mesh:

Year:  1998        PMID: 9613860

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  37 in total

1.  The COP9 signalosome regulates the Neurospora circadian clock by controlling the stability of the SCFFWD-1 complex.

Authors:  Qun He; Ping Cheng; Qiyang He; Yi Liu
Journal:  Genes Dev       Date:  2005-06-16       Impact factor: 11.361

Review 2.  Sleep as a translationally-relevant endpoint in studies of autism spectrum disorder (ASD).

Authors:  Galen Missig; Christopher J McDougle; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2019-05-06       Impact factor: 7.853

3.  Sleep in Neurodevelopmental Disorders.

Authors:  Anna J Esbensen; Amy J Schwichtenberg
Journal:  Int Rev Res Dev Disabil       Date:  2016

4.  Abnormal circadian rhythm of melatonin in Smith-Magenis syndrome patients with RAI1 point mutations.

Authors:  Philip M Boone; Russel J Reiter; Daniel G Glaze; Dun-Xian Tan; James R Lupski; Lorraine Potocki
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

5.  Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.

Authors:  L Potocki; D Glaze; D X Tan; S S Park; C D Kashork; L G Shaffer; R J Reiter; J R Lupski
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

6.  Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities.

Authors:  J C Hodge; E Mitchell; V Pillalamarri; T L Toler; F Bartel; H M Kearney; Y S Zou; W H Tan; C Hanscom; S Kirmani; R R Hanson; S A Skinner; R C Rogers; D B Everman; E Boyd; C Tapp; S V Mullegama; D Keelean-Fuller; C M Powell; S H Elsea; C C Morton; J F Gusella; B DuPont; A Chaubey; A E Lin; M E Talkowski
Journal:  Mol Psychiatry       Date:  2013-04-16       Impact factor: 15.992

Review 7.  Rhythms of life: circadian disruption and brain disorders across the lifespan.

Authors:  Ryan W Logan; Colleen A McClung
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

8.  Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome.

Authors:  Paulina Carmona-Mora; Carolina A Encina; Cesar P Canales; Lei Cao; Jessica Molina; Pamela Kairath; Juan I Young; Katherina Walz
Journal:  BMC Mol Biol       Date:  2010-08-25       Impact factor: 2.946

9.  Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.

Authors:  Melanie Lacaria; Wenli Gu; James R Lupski
Journal:  Am J Med Genet A       Date:  2013-05-23       Impact factor: 2.802

10.  Mouse models of genomic syndromes as tools for understanding the basis of complex traits: an example with the smith-magenis and the potocki-lupski syndromes.

Authors:  P Carmona-Mora; J Molina; C A Encina; K Walz
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.